ID | Term | Mouse gene |
Alleles | Background | Color Key |
MP:0002328 | abnormal airway resistance |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0000188 | abnormal circulating glucose level |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0008713 | abnormal cytokine level |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | B6.129P2-Pla2g4a | color key |
MP:0001406 | abnormal gait |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0002078 | abnormal glucose homeostasis |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0005335 | abnormal gonadal fat pad morphology |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0001790 | abnormal immune system physiology |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0001845 | abnormal inflammatory response |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0008751 | abnormal interleukin level |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0002511 | abnormal leukotriene C4 physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0002510 | abnormal leukotriene physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0005342 | abnormal lipid absorption |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0002451 | abnormal macrophage physiology |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | NOD.129P2(B6)-Pla2g4a | color key |
MP:0002516 | abnormal PGE2 physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0002451 | abnormal macrophage physiology |
Pla2g5 |
Pla2g5tm1Jarm/Pla2g5tm1Jarm | involves: 129 * C57BL/6J | color key |
MP:0002463 | abnormal neutrophil physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0002907 | abnormal parturition |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0002514 | abnormal prostaglandin physiology |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0002703 | abnormal renal tubule morphology |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0002651 | abnormal sciatic nerve |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0002519 | abnormal thromboxane physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0002502 | abnormal vasoactive mediator physiology |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0001878 | allergic response |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0002675 | asthenozoospermia |
Pla2g6 |
Pla2g6tm1Turk/Pla2g6tm1Turk | involves: 129X1/SvJ | color key |
MP:0001393 | ataxia |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0008079 | decreased CD8-positive T cell number |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0005087 | decreased acute inflammation |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0005087 | decreased acute inflammation |
Pla2g5 |
Pla2g5tm1Jarm/Pla2g5tm1Jarm | involves: 129 * C57BL/6J | color key |
MP:0001262 | decreased body weight |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0002727 | decreased circulating insulin level |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0005668 | decreased circulating leptin level |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0005012 | decreased eosinophil cell number |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0002492 | decreased IgE level |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0001876 | decreased inflammatory response |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0001876 | decreased inflammatory response |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0008567 | decreased interferon-gamma secretion |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | B6.129P2-Pla2g4a | color key |
MP:0001935 | decreased litter size |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0003402 | decreased liver weight |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0005351 | decreased susceptibility to autoimmune disorder |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | B6.129S2-Alox5/J | color key |
MP:0004800 | decreased susceptibility to experimental autoimmune encephalomyelitis |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | B6.129P2-Pla2g4a | color key |
MP:0005597 | decreased susceptibility to type I hypersensitivity reaction |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0005018 | decreased T cell number |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0008075 | decreased CD4-positive T cell number |
Pla2g10 |
Pla2g10Gt712Lex/Pla2g10Gt712Lex | involves: 129S/SvEvBrd * C57BL/6J | color key |
MP:0008561 | decreased tumor necrosis factor secretion |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | B6.129P2-Pla2g4a | color key |
MP:0001783 | decreased white adipose tissue amount |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0001405 | impaired coordination |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0005293 | impaired glucose tolerance |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | NOD.129P2(B6)-Pla2g4a | color key |
MP:0001524 | impaired limb coordination |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0008720 | impaired neutrophil migration |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0008719 | impaired neutrophil recruitment |
Alox5 |
Alox5tm1Bhk/Alox5tm1Bhk | either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) | color key |
MP:0005292 | improved glucose tolerance |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0000062 | increased bone density |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | B6.129S2-Alox5/J | color key |
MP:0005669 | increased circulating leptin level |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | B6.129S2-Alox5/J | color key |
MP:0005145 | increased circulating VLDL cholesterol level |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | B6.129S2-Alox5/J | color key |
MP:0002891 | increased insulin sensitivity |
Pla2g1b |
Pla2g1btm1Dyh/Pla2g1btm1Dyh | involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 | color key |
MP:0008908 | increased total fat pad weight |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | B6.129S2-Alox5/J | color key |
MP:0004031 | insulitis |
Pla2g4a |
Pla2g4atm1Tksh/Pla2g4atm1Tksh | NOD.129P2(B6)-Pla2g4a | color key |
MP:0000160 | kyphosis |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0002229 | neurodegeneration |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0002083 | premature death |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0001922 | reduced male fertility |
Pla2g6 |
Pla2g6tm1Turk/Pla2g6tm1Turk | involves: 129X1/SvJ | color key |
MP:0001922 | reduced male fertility |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0000692 | small spleen |
Alox5 |
Alox5tm1Fun/Alox5tm1Fun | involves: 129S2/SvPas * C57BL/6 | color key |
MP:0001263 | weight loss |
Pla2g6 |
Pla2g6tm1Tsu/Pla2g6tm1Tsu | involves: 129S2/SvPas * C57BL/6 | color key |